Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Bacterial cell membrane" refers to the phospholipid bilayer that encloses the cytoplasm of bacterial cells and serves functions including acting as a selective permeability barrier, site of metabolic processes like energy generation, and anchoring for proteins involved in signaling, secretion, and cell division[1][2][3][4][7][8][9]. It is composed primarily of phospholipids and proteins, and its properties (like charge, fluidity, and presence of domains) play crucial roles in bacterial survival and in mediating susceptibility or resistance to certain antibiotics such as daptomycin[1][7]. "Tumor cell membrane" denotes the plasma membrane of a cancer cell, which can have altered protein and lipid composition compared to normal cells, influencing signal transduction, adhesion, immune evasion, and drug sensitivity. Though not a molecular target in the classical sense (receptor, enzyme), both bacterial and tumor cell membranes are important as therapeutic targets: in bacteria, the membrane is a primary target for antibiotics that disrupt its integrity; in cancer, the membrane may be exploited for selective drug delivery or targeted by agents recognizing altered membrane components. **Note:** - The entry "bacterial and tumor cell membranes" is **not a standardized molecular or protein target**, but rather a description of two broad classes of cellular structures. If you seek a specific membrane protein, lipid, or receptor (e.g., "bacterial phosphatidylglycerol" or "tumor cell EGFR"), further specification is recommended. - Molecular classification as a "membrane" is generic and not equivalent to receptor, enzyme, or transporter; further breakdown would be required for structured target databases. - In summary, "bacterial and tumor cell membranes" often serve as broad **therapeutic targets** for drugs aiming to disrupt membrane integrity or facilitate selective delivery, rather than traditional drug targets like individual proteins or enzymes[7].
Disruption of membrane integrity (antibacterial agents like daptomycin and polymyxins) Enhanced drug delivery (exploitation of tumor cell membrane properties, as with nanoparticles and liposomal drugs)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane and tumor cell membrane.